California State Teachers Retirement System Trims Stake in Xylem Inc. (NYSE:XYL)

California State Teachers Retirement System lessened its position in shares of Xylem Inc. (NYSE:XYL – Get Rating) by 0.9% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 300,986 shares of the industrial products company’s stock after selling 2,855 shares during the quarter. California State Teachers Retirement System’s holdings in Xylem were worth $26,294,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of Xylem by 1.0% during the third quarter. Vanguard Group Inc. now owns 20,814,960 shares of the industrial products company’s stock worth $1,818,395,000 after acquiring an additional 209,454 shares during the last quarter. BlackRock Inc. grew its position in Xylem by 1.4% during the 3rd quarter. BlackRock Inc. now owns 18,680,184 shares of the industrial products company’s stock worth $1,631,902,000 after purchasing an additional 262,913 shares during the last quarter. Invesco Ltd. increased its stake in Xylem by 53.6% in the first quarter. Invesco Ltd. now owns 3,828,177 shares of the industrial products company’s stock valued at $326,390,000 after purchasing an additional 1,335,241 shares during the period. Baillie Gifford & Co. raised its holdings in shares of Xylem by 1.5% in the third quarter. Baillie Gifford & Co. now owns 2,964,784 shares of the industrial products company’s stock valued at $259,003,000 after buying an additional 44,430 shares during the last quarter. Finally, First Trust Advisors LP boosted its stake in shares of Xylem by 399.3% during the first quarter. First Trust Advisors LP now owns 2,951,349 shares of the industrial products company’s stock worth $251,632,000 after buying an additional 2,360,214 shares during the period. Institutional investors and hedge funds own 83.57% of the company’s stock.

Xylem Stock Down 2.5 %

XYL opened at $94.73 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.89 and a quick ratio of 1.39. The business has a 50 day simple moving average of $105.23 and a 200-day simple moving average of $103.19. The stock has a market capitalization of $17.08 billion, a P/E ratio of 48.33, a P/E/G ratio of 2.52 and a beta of 1.07. Xylem Inc. has a 12 month low of $72.08 and a 12 month high of $118.58.

Xylem (NYSE:XYL – Get Rating) last released its quarterly earnings data on Tuesday, February 7th. The industrial products company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.79 by $0.13. Xylem had a return on equity of 15.72% and a net margin of 6.43%. The firm had revenue of $1.51 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period last year, the business posted $0.63 EPS. Xylem’s quarterly revenue was up 13.8% on a year-over-year basis. On average, equities analysts anticipate that Xylem Inc. will post 3.2 earnings per share for the current fiscal year.

Xylem Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 22nd. Investors of record on Wednesday, February 22nd will be paid a $0.33 dividend. This is an increase from Xylem’s previous quarterly dividend of $0.30. This represents a $1.32 annualized dividend and a yield of 1.39%. The ex-dividend date of this dividend is Tuesday, February 21st. Xylem’s dividend payout ratio (DPR) is presently 67.35%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on XYL shares. Cowen boosted their price target on Xylem from $115.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, February 14th. Raymond James cut Xylem from a “market perform” rating to an “underperform” rating in a research report on Wednesday, January 4th. Morgan Stanley increased their price objective on Xylem from $105.00 to $115.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 18th. Stifel Nicolaus raised Xylem from a “hold” rating to a “buy” rating and increased their price objective for the stock from $115.00 to $124.00 in a research report on Tuesday, January 24th. Finally, Citigroup decreased their price objective on Xylem from $123.00 to $121.00 and set a “neutral” rating for the company in a research report on Wednesday, February 8th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Xylem has an average rating of “Hold” and an average price target of $114.80.

Insider Activity at Xylem

In related news, SVP Hayati Yarkadas sold 15,942 shares of the firm’s stock in a transaction that occurred on Thursday, March 2nd. The stock was sold at an average price of $100.43, for a total value of $1,601,055.06. Following the completion of the transaction, the senior vice president now directly owns 12,146 shares of the company’s stock, valued at approximately $1,219,822.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Xylem news, SVP Hayati Yarkadas sold 15,942 shares of the firm’s stock in a transaction on Thursday, March 2nd. The stock was sold at an average price of $100.43, for a total transaction of $1,601,055.06. Following the completion of the transaction, the senior vice president now owns 12,146 shares of the company’s stock, valued at $1,219,822.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick Decker sold 56,298 shares of the firm’s stock in a transaction on Monday, March 13th. The stock was sold at an average price of $98.19, for a total value of $5,527,900.62. Following the transaction, the chief executive officer now directly owns 287,564 shares of the company’s stock, valued at approximately $28,235,909.16. The disclosure for this sale can be found here. 0.89% of the stock is currently owned by company insiders.

Xylem Company Profile

(Get Rating)

Xylem, Inc engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water.